Honest reporting and elucidation of very serious adverse events: a lesson to us all
Digital necrosis associated with chronic cold haemagglutinin disease
A rare presentation of anaplastic oligodendroglioma metastatic to bone marrow, mimicking blast cells
How I manage patients with grey zone lymphoma
Recent advances in therapy of chronic lymphocytic leukaemia
The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials
Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12
A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells
18F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma
Trends in primary central nervous system lymphoma incidence and survival in the U.S.
Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia
High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group
The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma
Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study
mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease
NAP1L1-MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukaemia
Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach
Selective downregulation of HLA-C and HLA-E in childhood acute lymphoblastic leukaemia
Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohort
Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization
Can exome scans be expected to be part of real-time decision-making in patients with haematological cancers?